West Pharmaceutical Services (WST) FCF Payout Ratio (2009 - 2026)

West Pharmaceutical Services (WST) has reported FCF Payout Ratio for 18 consecutive years, with 0.19 the latest figure, recorded in Q2 2026.

• Quarterly FCF Payout Ratio rose 31.13% year-over-year to 0.19 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.14 (down 18.25% YoY) and the FY2025 annual result came in at 0.13, down 38.96% from the prior year.
• FCF Payout Ratio slipped to 0.19 in Q2 2026 per WST's latest filing, from 0.33 in the prior quarter.
• Over the last five years, FCF Payout Ratio for WST reached as high as 0.53 in Q1 2024 and fell as low as 0.09 in Q4 2025.
• A 5-year average of 0.19 and a median of 0.15 in 2023 frame the typical range for FCF Payout Ratio.
• Annual changes were most pronounced in 2022 — FCF Payout Ratio tumbled 57.66% — and 2024, when it surged 111.53%.
• Year by year, FCF Payout Ratio stood at 0.1 in 2022, then grew by 9.39% to 0.11 in 2023, then soared by 58.22% to 0.18 in 2024, then sank by 49.72% to 0.09 in 2025, then soared by 115.21% to 0.19 in 2026.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.19, 0.33, and 0.09 for Q2 2026, Q1 2026, and Q4 2025 respectively.